114 related articles for article (PubMed ID: 28766835)
1. The expression profile and prognostic value of APE/Ref-1 and NPM1 in high-grade serous ovarian adenocarcinoma.
Fan X; Wen L; Li Y; Lou L; Liu W; Zhang J
APMIS; 2017 Oct; 125(10):857-862. PubMed ID: 28766835
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic significance of APE1/Ref-1 and NPM1 proteins in high-grade ovarian serous cancer.
Londero AP; Orsaria M; Tell G; Marzinotto S; Capodicasa V; Poletto M; Vascotto C; Sacco C; Mariuzzi L
Am J Clin Pathol; 2014 Mar; 141(3):404-14. PubMed ID: 24515769
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ape1/ref-1 subcellular localization in non-small cell lung carcinomas.
Puglisi F; Aprile G; Minisini AM; Barbone F; Cataldi P; Tell G; Kelley MR; Damante G; Beltrami CA; Di Loreto C
Anticancer Res; 2001; 21(6A):4041-9. PubMed ID: 11911289
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of the apurinic/apyrimidinic endonuclease 1 (APE1)/nucleophosmin (NPM1) interaction that display anti-tumor properties.
Poletto M; Malfatti MC; Dorjsuren D; Scognamiglio PL; Marasco D; Vascotto C; Jadhav A; Maloney DJ; Wilson DM; Simeonov A; Tell G
Mol Carcinog; 2016 May; 55(5):688-704. PubMed ID: 25865359
[TBL] [Abstract][Full Text] [Related]
5. APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC.
Malfatti MC; Gerratana L; Dalla E; Isola M; Damante G; Di Loreto C; Puglisi F; Tell G
J Exp Clin Cancer Res; 2019 Jul; 38(1):309. PubMed ID: 31307523
[TBL] [Abstract][Full Text] [Related]
6. Impact of apurinic/apyrimidinic endonuclease 1/redox factor-1 on treatment response and survival in oral squamous cell carcinoma.
Hsia KT; Liu CJ; Mar K; Lin LH; Lin CS; Cheng MF; Lee HS; Chiu SY
Head Neck; 2016 Apr; 38(4):550-9. PubMed ID: 25482590
[TBL] [Abstract][Full Text] [Related]
7. Subcellular localization of APE1/Ref-1 in human hepatocellular carcinoma: possible prognostic significance.
Di Maso V; Avellini C; Crocè LS; Rosso N; Quadrifoglio F; Cesaratto L; Codarin E; Bedogni G; Beltrami CA; Tell G; Tiribelli C
Mol Med; 2007; 13(1-2):89-96. PubMed ID: 17515960
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of Ape/Ref-1 subcellular expression in stage I-III breast carcinomas.
Puglisi F; Barbone F; Tell G; Aprile G; Pertoldi B; Raiti C; Kelley MR; Damante G; Sobrero A; Beltrami CA; Di Loreto C
Oncol Rep; 2002; 9(1):11-7. PubMed ID: 11748448
[TBL] [Abstract][Full Text] [Related]
9. Apurinic apyrimidinic endonuclease/redox effector factor 1 immunoreactivity and grading in hepatocellular carcinoma risk of relapse after liver transplantation.
Avellini C; Orsaria M; Baccarani U; Adani GL; Lorenzin D; Bresadola V; Bresadola F; Beltrami CA
Transplant Proc; 2010 May; 42(4):1204-8. PubMed ID: 20534262
[TBL] [Abstract][Full Text] [Related]
10. Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 Could Serve as a Potential Serological Biomarker for the Diagnosis and Prognosis of Oral Squamous Cell Carcinoma.
Xie J; Li Y; Kong J; Li C
J Oral Maxillofac Surg; 2019 Apr; 77(4):859-866. PubMed ID: 30611690
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the expression of the apurinic/apyrimidinic endonuclease-1/redox factor-1 (APE1/Ref-1) in human ovarian cancer and indentification of the therapeutic potential of APE1/Ref-1 inhibitor.
Zhang Y; Wang J; Xiang D; Wang D; Xin X
Int J Oncol; 2009 Nov; 35(5):1069-79. PubMed ID: 19787261
[TBL] [Abstract][Full Text] [Related]
12. Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology.
Vascotto C; Lirussi L; Poletto M; Tiribelli M; Damiani D; Fabbro D; Damante G; Demple B; Colombo E; Tell G
Oncogene; 2014 May; 33(22):2876-87. PubMed ID: 23831574
[TBL] [Abstract][Full Text] [Related]
13. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas.
Tanner B; Grimme S; Schiffer I; Heimerdinger C; Schmidt M; Dutkowski P; Neubert S; Oesch F; Franzen A; Kölbl H; Fritz G; Kaina B; Hengstler JG
Gynecol Oncol; 2004 Feb; 92(2):568-77. PubMed ID: 14766249
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of human apurinic/apyrimidinic endonuclease (APE/Ref-1) expression in rectal cancer treated with preoperative radiochemotherapy.
Kim JS; Kim JM; Liang ZL; Jang JY; Kim S; Huh GJ; Kim KH; Cho MJ
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):130-7. PubMed ID: 21075552
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of FOXM1 and Gli-1 protein expression in high-grade ovarian serous carcinoma].
Zhang J; Li ZY; Duan XJ; Fan XM; Liu WN; Li YH
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):904-908. PubMed ID: 27998466
[No Abstract] [Full Text] [Related]
16. Prognostic significance of APE1 cytoplasmic localization in human epithelial ovarian cancer.
Sheng Q; Zhang Y; Wang R; Zhang J; Chen B; Wang J; Zhang W; Xin X
Med Oncol; 2012 Jun; 29(2):1265-71. PubMed ID: 21479902
[TBL] [Abstract][Full Text] [Related]
17. Thymidine kinase 1 expression in ovarian serous adenocarcinoma is superior to Ki-67: A new prognostic biomarker.
Wang J; Liu Q; Zhou X; He Y; Guo Q; Shi Q; Eriksson S; Zhou J; He E; Skog S
Tumour Biol; 2017 Jun; 39(6):1010428317706479. PubMed ID: 28651488
[TBL] [Abstract][Full Text] [Related]
18. The intracellular localization of APE1/Ref-1: more than a passive phenomenon?
Tell G; Damante G; Caldwell D; Kelley MR
Antioxid Redox Signal; 2005; 7(3-4):367-84. PubMed ID: 15706084
[TBL] [Abstract][Full Text] [Related]
19. [The expression of APE1 and its correlation with prognostic significance after 252Cf radiotherapy in cervical cancer].
Qing Y; Wang D; Lei X; Xiang DB; Li MX; Li ZP; Shan JL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):125-8. PubMed ID: 19292061
[TBL] [Abstract][Full Text] [Related]
20. Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.
Moore DH; Michael H; Tritt R; Parsons SH; Kelley MR
Clin Cancer Res; 2000 Feb; 6(2):602-9. PubMed ID: 10690545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]